{"name":"Genetix Biotherapeutics Inc.","slug":"genetix-biotherapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"LentiGlobin BB305 Drug Product","genericName":"LentiGlobin BB305 Drug Product","slug":"lentiglobin-bb305-drug-product","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"LentiGlobin BB305 Drug Product","genericName":"LentiGlobin BB305 Drug Product","slug":"lentiglobin-bb305-drug-product","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNa1BiOGVyb3dtTUFfTmhLRDVrQVpVc2lmUzRjbWdLREF6S19yZGx4RlZoZ3lmWjZqUE4teUQ2RlVRVjB2cDJ3RXdsaUd1U1FqLS02WVF5eWl3LU1td0c3ZHdqZEhIeUpsREcyRFZaaGRHVklOS3RxVXEzejdkcndtTFdZOHRMVGVOdEwyZVV2RkVzanN4RHBpWmFYZXE2dTkxenEwTURwUjE?oc=5","date":"2026-03-26","type":"pipeline","source":"Contract Pharma","summary":"Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO - Contract Pharma","headline":"Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNYmd1OXJqa1pUMnlrdFlVcDdXeVg1eXZfUUkxSno0MGQxbHZaVU1pR0xkbGZEOU00V1NUQ2x1eHlvX1hYdnN3Qlk5dzAxdVRPd0MwYVViOTNRVGxtaWJNNTJHM283WWtBZWgxUGQwcDVsR3BITW1YSmstbFd2NVJvZDNsbTQ1SWdSSDkzZ0tFbW1oRUNOSkpVbk9heGtKc1JaX1FLc1RBczFlLWhIbktZMW1iOXJkb3pGdDZBOA?oc=5","date":"2026-03-25","type":"regulatory","source":"Reuters","summary":"US FDA approves Denali's genetic disorder therapy for children - Reuters","headline":"US FDA approves Denali's genetic disorder therapy for children","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNQmVCajdDbEZZOEZ5U0lmNVg0X0tldkEyc19VZDJib3N4RDNoM1hDWTkyazZxTnE4Q3g4bE5GdmM3ay14NkRGenBCM1JHSXIyZTJxLU9zR01rM2xKSk5Ya2ZvblBpYkI2UUFkcnVLX19rdWMwMXRXNGhhWi1rOFI5NGRkanlhUXVkdWVqajJaUE44Tm1yNmpNM2liU1ZUQmNNVWg3ai1tX0NfYzRlQ1pKUVQxSjZGLXNuY3RwXw?oc=5","date":"2026-02-26","type":"pipeline","source":"prnewswire.com","summary":"Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™ - prnewswire.com","headline":"Orsini Now Distributing Gene Therapies LYFGENIA™, ZYNTEGLO™, SKYSONA™","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPVTFtXzZ4ci1zRDg3T1hOdUpKXzBtTjVvbEdIelpMOWpZWEZPSTA1WXNsSTlPb3ZPZC10UXFxNzVrTWdJT3Z1Sk5IMUZxU1F3SjBTNm9MTmd6TGFhaXlxSGdqeFhrMklYTnRJVWRSVGRVRmpmVXBvX1RfU1hrZWVKNkVJU0t3RTNCTHQxTDZPUHRFdkdHQ3BfYzRSZVhORm5naHNzY0hYS05XZi1vSVdNNG00c0RjT2dSMjZual82Tkc?oc=5","date":"2026-02-23","type":"pipeline","source":"BioSpace","summary":"Sickle Cell Gene Therapies Casgevy and Lyfgenia Still Lacking Traction 2 Years In - BioSpace","headline":"Sickle Cell Gene Therapies Casgevy and Lyfgenia Still Lacking Traction 2 Years In","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQdTByWmtVbWFNNXNySUVUX1VCbkcwY3ZGb0YtR0hZYnJfUHEwVE1FUEszRzhSQlQ3cFl5VDRkTTFFaWNSbkJGY25aTzkwMkl3T2pYUWlQZWU5aFhlTWY2NTRzUjVpWmt1cE9vUDBJNXhPYjJCbkFVckhyRWhLa0lvTUFib2VSWnJBUk9SdUJfeHJXbUtVYWxFTkJ3cU5pZHlYS2o3YlJYdHR1N01hdi1IMWE1TWVCT3NSUk5iOUpkLVJGdDZqeE1HbA?oc=5","date":"2026-01-12","type":"deal","source":"Contract Pharma","summary":"Minaris, Genetix Expand Manufacturing Partnership to Increase Production of LYFGENIA - Contract Pharma","headline":"Minaris, Genetix Expand Manufacturing Partnership to Increase Production of LYFGENIA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNUEtTenZlOHYzQnJTaTE3aHgyVzQzcmY0cVU5SnBPQnc5YzZYaXFOVTVlMjNCN1ZPeEN2dG92ZlM2d2d4dFphQ0xKNVRyOVNNTE5MS2ZHTy1xT3UwM09vUlNpQmRvT2ZXVEIzV0otNi10RVFqeTZsSXJSSHJwUTdyM3NNTWIwUDlsTXVfQlc0UQ?oc=5","date":"2026-01-06","type":"pipeline","source":"drugdiscoverytrends.com","summary":"50 cell and gene therapy leaders to watch in 2026 - drugdiscoverytrends.com","headline":"50 cell and gene therapy leaders to watch in 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5rMi1PSjJUMC1GWHVnMGZrd3BSdjZTODJsZHZ1bHpZMVBidi1kLTl1UkpPbkQxSFkzRGRxelhoTGw0blBJYTd4YzZRTy1LaGlNeklGSG9vVURaVDVOV1VoN1Z1Rk1IOEg4dVVwOHRn?oc=5","date":"2025-11-14","type":"pipeline","source":"Labiotech.eu","summary":"10 gene therapy companies with promising treatments to watch - Labiotech.eu","headline":"10 gene therapy companies with promising treatments to watch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNWFhYdzNxTzZVeDhDdnZRQ0c1VG4tY3dwa3V2QzdmMGktUFh5b2w5TWxZZ1F6eGN1anB6RzI4VVZwcm9Sc1N3clJ3SDZVems4dGVIbXVXdHhnREJUZ2EwVnVacTYyNUdnNnVBbW1kcGFhVnZWUXJyWmdvc3dMRV9xdkpLM3A?oc=5","date":"2025-09-27","type":"pipeline","source":"marketscreener.com","summary":"Genetix Biotherapeutics, Inc. Stock (BLUE) - Quote Nasdaq - marketscreener.com","headline":"Genetix Biotherapeutics, Inc. Stock (BLUE) - Quote Nasdaq","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQNXptdll6ajV3UVg4WFZ0cmZzTFc0aGdGR1ZuTnZVVV9NM2s3MGVoSXV2dWpKQlJxendCR3Bxa1ZoRDIwZU45MTFJNTRMWndERWJndmdWQm90QUI3QzlydHRKeVpDaEwyaGpIaEt4X18yZF9xODkxeEZ5UThnUUxKdlpTbjZHUjl6MjNrWmNfbllWbzd0?oc=5","date":"2025-09-25","type":"pipeline","source":"Medical Marketing and Media","summary":"Rx Rundown: Pfizer, Genetix Biotherapeutics, Sanofi and more - Medical Marketing and Media","headline":"Rx Rundown: Pfizer, Genetix Biotherapeutics, Sanofi and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNN2ZjcG40Rmg3U3RzdnlsbnpDOGtqaV9yZzR1akJaM0FFX1d6eEpZb21kMjdNbjE2SDV2dnNHRnp3aUxCQk5PSzhYb2J1VEtLM2JDMHlLSWRrUHdJU3ZpZmFKZjdVVGtlZEtVYmVJUlI5Q2dqN1F5ckZOTkdvc1NfMHRzVWhvbzJZdDJ2R3BFM0UwOWZRbTlZaE84Y2RpYnBHcGRnc2UyOHQ0Zw?oc=5","date":"2025-09-19","type":"pipeline","source":"Pharmaceutical Technology","summary":"Bluebird bio flies to pastures new with Genetix rebranding - Pharmaceutical Technology","headline":"Bluebird bio flies to pastures new with Genetix rebranding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZE5zQ2tId1p6VUd4Y0V6X21qdEtCOWg4UHlpN2JrcFJZaUhyZ0pRLVRVZ3J3Sm4yY01fZEtVcjRza0ZFZnhaWjNRZFVYcGU3UkJ2WTdzUU8wcW4wTUY2OXdONnNGel9QZlFSWmF3SkNrWHpyallIZC1DM1cyYm5BanFyVS0zRV9uYTJEMTlfc2VCcTZRNTZtRUc0cERSM1diUlROVHYwSjk?oc=5","date":"2025-09-18","type":"deal","source":"Fierce Pharma","summary":"After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics - Fierce Pharma","headline":"After buyout, bluebird bio hatches familiar new branding as Genetix Biotherapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPakRZRml3Q25rV09zZm40ZkxqazJYaW9QSktZQldRVEwyMFJTa2Y0R0MxNjJyVkxZTi1RYWdLVmxnelJpZFFwR0c4aC1YN2xnNUQzYnpqZmxXRmlqeDl0YnlZcHN4Rmo2aVdqYmlNd0JuNGJPblNrc1poVVpwRGpMM1UwRG5VbkRGNlpUN3hzT29QYXZNNGhPQWRwZm1kQmREcEJFOEEyMVA1NEtwOFp2bEJLVXRqNnFVOFhYbGlObFIwVGgzNWRfb21HTXdsUE1DN1E4Tno2RWg?oc=5","date":"2025-09-18","type":"pipeline","source":"businesswire.com","summary":"bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots - businesswire.com","headline":"bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}